Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

KCNMA1 activates immune response. 3 / 3

| 3

➶

reach

"Taken together, these results indicate that less toxic SLO variants that produce strands and altered pores could promote a more robust immune response through enhanced cytokine secretion."

23744055

➶

reach

"Protective immunity is mediated by neutralization of active SLO."

23300245

➶

reach

"A non toxic SLO derivate elicits protective immunity against lethal GAS challenge in a murine infection model."

26635795

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

KCNMA1 activates immune response. 3 / 3

Our Sources:

Databases

Reading